LRRFIP1 Antikörper (AA 1-315)
-
- Target Alle LRRFIP1 Antikörper anzeigen
- LRRFIP1 (Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1))
-
Bindungsspezifität
- AA 1-315
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LRRFIP1 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Leucine-rich repeat flightless-interacting protein 1 protein (1-315AA)
- Isotyp
- IgG
- Top Product
- Discover our top product LRRFIP1 Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- LRRFIP1 (Leucine Rich Repeat (In FLII) Interacting Protein 1 (LRRFIP1))
- Andere Bezeichnung
- LRRFIP1 (LRRFIP1 Produkte)
- Synonyme
- hm:zeh1367 antikoerper, lrrfip1 antikoerper, wu:fc06b04 antikoerper, wu:fi15c07 antikoerper, zeh1367 antikoerper, LRRFIP1 antikoerper, AU024550 antikoerper, Fliiap1 antikoerper, FLAP-1 antikoerper, FLAP1 antikoerper, FLIIAP1 antikoerper, GCF-2 antikoerper, GCF2 antikoerper, HUFI-1 antikoerper, TRIP antikoerper, leucine rich repeat (in FLII) interacting protein 1a antikoerper, LRR binding FLII interacting protein 1 antikoerper, leucine rich repeat (in FLII) interacting protein 1 antikoerper, lrrfip1a antikoerper, LRRFIP1 antikoerper, Lrrfip1 antikoerper
- Hintergrund
-
Background: Transcriptional repressor which preferentially binds to the GC-rich consensus sequence (5\\\'-AGCCCCCGGCG-3\\\') and may regulate expression of TNF, EGFR and PDGFA. May control smooth muscle cells proliferation following artery injury through PDGFA repression. May also bind double-stranded RNA. Positively regulates Toll-like receptor (TLR) signaling in response to agonist probably by competing with the negative FLII regulator for MYD88-binding.
Aliases: FLAP 1 antibody, FLAP1 antibody, FLIIAP 1 antibody, FLIIAP1 antibody, GC binding factor 2 antibody, GC-binding factor 2 antibody, GCF 2 antibody, GCF2 antibody, HUFI 1 antibody, HUFI1 antibody, Leucine rich repeat (in FLII) interacting protein 1 antibody, Leucine rich repeat flightless interacting protein 1 antibody, Leucine-rich repeat flightless-interacting protein 1 antibody, LRR FLII interacting protein 1 antibody, LRR FLII-interacting protein 1 antibody, LRRF1_HUMAN antibody, LRRFIP 1 antibody, Lrrfip1 antibody, MGC10947 antibody, MGC119738 antibody, MGC119739 antibody, NEDD8 conjugating enzyme antibody, TAR RNA interacting protein antibody, TAR RNA-interacting protein antibody, Transcription factor 9 like antibody, TRIP antibody
- UniProt
- Q32MZ4
-